As mounting evidences reveal direct connections between R-loops and cancer [58], the elevated genome instability caused by MRS after WRNIP1 depletion in cells with dysfunctional ATR checkpoint puts forward WRNIP1 as a target to further sensitize cancer cells to inhibitors of ATR or CHK1, which are currently under clinical evaluation. This evidence concerns the gene ATR and cancer.